Navigation Links
OMICS Group International is the New Publisher of 14 Noble Laureates Supporting Cellular and Molecular Biology : 60 Years Old Reputed Medline Indexed Journal
Date:9/14/2013

Henderson, NV (PRWEB) September 14, 2013

OMICS Group International, a leading Open Access Online publisher and Scientific Event Organizer, announces with pride the collaboration with 60 years old journal of Cellular and Molecular Biology. Dr. Srinubabu Gedela, the Managing Director of OMICS Group International signed an agreement with Professor and Dean Raymond J. Wegmann, the founding editor of the prestigious journal, on September 13, 2013 at OMICS Office.

Established in the year 1950, Cellular and Molecular Biology journal is an interdisciplinary publication that publishes original research work in the form of articles, comments and reviews integrating molecular biology with fields like biophysics, biochemistry, enzymology, physiology and biotechnology in a dynamic cell and tissue biology environment, applied to human, animals, plants tissues as well to microbial and viral cells. Under the surveillance of 14 noble laureates namely Werner ARBER, Günter BLOBEL, Christian DE DUV, Leo ESAKI, Pierre-Gilles de GENNES, Ivar GIÆVER, Robert HUBER, Harold KROTO, Jean-Marie LEHN, Hartmut MICHEL, Ferid MURAD, Ilya PRIGOGINE†, Jens C. SKOU, Torsten N. WIESEL, Cellular and Molecular Biology has achieved the pinnacle of success and will continue to accomplish the same. The journal is therefore open to intense interdisciplinary exchanges in medical, dental, veterinary, pharmacological, botanical and biological researches for the demonstration of these multiple links.

Cellular and Molecular Biology (ISSN: 1165-158X) is the 301st journal under its open access umbrella of OMICS Publishing Group and aspires for its continued success with the support of eminent editors from around the world. Indexed/Abstracted in more than 35 retrieval Journals, and among them: MEDLINE/PubMed, BIOSIS Database, Current Contents, Index Medicus, PASCAL/CNRS
Database, Cam. Sci. Abstr., CAB Inter., Chem. Abstr. Service, RIS in Reference Update etc are the prime platforms.

Dr. Srinubabu Gedela is the founder member of the OMICS Group International that publishes more than 300 scholarly open access journals, peer reviewed online journals in sciences, engineering & technology, pharmaceutical and management disciplines. OMICS Group is an exemplary event organizer that conducts 100 International scientific conferences, workshops and events across the globe. With offices in India, USA, Europe, Dubai and Asia Pacific, OMICS Group International tied up with 100 scientific associations and agencies to make healthcare information open access.

Born in France, in the year 1923, Dr. Raymond J. Wegmann, has a multifaceted personality as a researcher, academician, publisher and scholar. Dr. Raymond attained his Doctor of Medicine in Paris and he has a Masters degree in Arts and Philosophy. He has got diplomas in Pathology, Bacteriology, Coprology, Hematology, Serology, and National Diploma of Specialist in Biology to his credit. He is a National Expert in the fields of Toxicology, Pharmacology and Pathology. He holds several prestigious positions as organizing committee member, Director and founder and is a member of many reputed scientific societies like American Chemical Society, American Heart Association, SIRMCE, etc. He has authored eight Science books and worked as co-author for four other books since 1960 to date. He is the founder and Editor-in-Chief of the ANNALES d'HISTOCHIMIE and Editor-in-Chief of CELLULAR & MOLECULAR BIOLOGY. He has got several meritorious distinctions and awards to his credit. Owing to what controversies Dr. Wegmann is possessing with other publishers he stated that, “OMICS Publishing Group is a better publisher than any other publishing house.”

The agreements between the two publishing groups attain significance at this juncture, where Dr. Raymond J. Wegmann personally visited and signed the agreement in the presence of Dr. Srinubabu Gedela at the office of OMICS Group where he discussed and shared his experiences and upcoming ventures with 500 employees of OMICS Group for 3 successive days.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11122111.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Hospital readmission rates linked to availability of care, socioeconomics
2. Researchers to use novel metabolomics technology for COPD
3. Neuroeconomics to study decision-making in anxious individuals
4. Classifying neural circuit dysfunctions using neuroeconomics
5. Grant funds West Coast Metabolomics Center
6. Expanding database enables discoveries in emerging field of metabolomics
7. New era in metabolomics begins at University of Michigan
8. Ontario Genomics Institute invests in stem cell technology at Tissue Regenerative Therapeutics
9. Sociology, economics researchers receive grant to study development across the human lifespan
10. Game-based economics research explains why we roll the dice on flu shots
11. The new age of proteomics: An integrative vision of the cellular world
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology: